@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr: a skos:ConceptScheme .
jvr:-D26CQDP7-F
  skos:prefLabel "Pharmacocinétique"@fr, "Pharmacokinetics"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-VGBMKR2G-Z .

jvr:-VGBMKR2G-Z
  skos:inScheme jvr: ;
  skos:prefLabel "Biological Availability"@en, "Biodisponibilité"@fr ;
  skos:altLabel "Bioavailability"@en, "Biologic Availability"@en, "Disponibilité physiologique"@fr, "Availability, Biological"@en, "Availability, Biologic"@en, "Disponibilité biologique"@fr, "Physiologic Availability"@en, "Availability, Physiologic"@en ;
  skos:hiddenLabel "Équivalence des disponibilités"@fr, "Availability Equivalency"@en, "Équivalence des biodisponibilités"@fr ;
  a mesh:Descriptor, skos:Concept ;
  dc:modified "2016-06-16"^^xsd:date ;
  dc:established "1979-01-01"^^xsd:date ;
  skos:definition "The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action."@en ;
  skos:broader jvr:-D26CQDP7-F ;
  dc:created "1999-01-01"^^xsd:date ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D001682> .